How low oxygen helps TB bacteria wreck immune cells

Tuberculosis forms granulomas, organized immune-cell structures that surround the bacteria. These granulomas can grow and then die in a way that helps the bacteria spread, but how that happens has been unclear. Using a tuberculosis model, researchers led by Lalita Ramakrishnan set out to trace the steps by which granulomas enlarge and become necrotic. Their work focused on interactions between the bacteria and the macrophages, the immune cells that normally eat and destroy microbes. They found that a bacterial virulence factor called EsxA plays a central role from the earliest stages. EsxA damages mitochondria inside infected macrophages and triggers apoptosis, a programmed cell death process. At first, the dying macrophages are taken up by newly arriving macrophages, a cleanup process that temporarily keeps the structure intact. But as the core of the granuloma grows, it becomes low in oxygen. That low-oxygen state activates a host response driven by Hypoxia Inducible Factor-1. The study follows how these sequential events—bacterial damage, cell death, recruitment, and oxygen loss—unfold in the granuloma environment.

In the tuberculosis model the team used, two linked stages of disease progression—granuloma enlargement and necrosis—both depended on the mycobacterial virulence factor EsxA. The investigators observed that EsxA causes mitochondrial damage and triggers apoptosis specifically in infected macrophages. Early on, this apoptosis is balanced by neighboring macrophages that engulf the dying cells, a standard tissue maintenance mechanism. But as the granuloma core enlarges it becomes hypoxic, and that low-oxygen condition induces Hypoxia Inducible Factor-1 (HIF-1) in macrophages. HIF-1 in turn suppresses mitochondrial respiration, changing macrophage metabolism. Because mitochondria are already being targeted by EsxA, the HIF-1–driven suppression of respiration makes macrophages more sensitive to EsxA’s mitotoxicity. The result is accelerated apoptosis of these sensitized macrophages. Clearance cannot keep up with the increased death rate, and mycobacterium-rich necrotic debris accumulates in the granuloma cores. These results link a specific bacterial factor, EsxA, with a host metabolic adaptation, HIF-1 activation, to explain the shift from contained infection to necrotic lesions.

The study highlights a dynamic interplay between a bacterial weapon and a host survival program that paradoxically helps the infection spread. By showing that granuloma necrosis depends both on EsxA and on the host’s hypoxia response via Hypoxia Inducible Factor-1, the findings point to two nodes in the disease process: the mycobacterial virulence factor that damages mitochondria and the host metabolic switch that makes macrophages more vulnerable. That framing narrows the question of how tuberculosis transmission emerges from within the granuloma and suggests new ways to think about interventions. Rather than treating only the bacteria, it may be important to consider how host responses to low oxygen contribute to tissue breakdown. Future work, building on this model, can explore whether interrupting EsxA activity or modifying the HIF-1–linked metabolic state changes the balance between controlled infection and the necrosis that releases bacteria. These insights come from observing the sequence of events in a tuberculosis model, and they underscore how tightly linked bacterial strategies and host adaptations are in driving disease outcomes.